Cargando…

FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma

FOXA1 is associated with malignant tumors, but the function of FOXA1 in EOC is unclear. HDAC3 can influence the proliferation, migration and invasion ability of EOC. In this study, we wanted to explore the function of FOXA1 in ovarian cancer and the relationship between HDAC3 and FOXA1.The expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lou, Tong, Liu, Chongdong, Qu, Hong, Zhang, Zhiqiang, Wang, Shuzhen, Zhuang, Huiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740004/ https://www.ncbi.nlm.nih.gov/pubmed/34991620 http://dx.doi.org/10.1186/s12967-021-03224-3

Ejemplares similares

Comparison of Laparoscopy and Laparotomy in Surgical Staging of Apparent Early Ovarian Cancer: 13-year Experience
por: Lu, Qi, et al.
Publicado: (2016)

CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway
por: Lu, Qi, et al.
Publicado: (2020)

Significance of the NOR1-FOXA1/HDAC2-Slug regulatory network in epithelial-mesenchymal transition of tumor cells
por: Wang, Wei, et al.
Publicado: (2016)

Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2
por: Xu, Yahong, et al.
Publicado: (2023)

Expression and prognostic value of CLIC1 in epithelial ovarian cancer
por: Yu, Wentao, et al.
Publicado: (2018)

HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome
por: He, Xiaoting, et al.
Publicado: (2023)

Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression
por: Thanan, Raynoo, et al.
Publicado: (2020)

Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics
por: Qu, Hong, et al.
Publicado: (2016)

Foxa1 and Foxa2 in thymic epithelial cells (TEC) regulate medullary TEC and regulatory T-cell maturation
por: Lau, Ching-In, et al.
Publicado: (2018)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
por: Xu, Long, et al.
Publicado: (2022)

Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma
por: Feng, Ying, et al.
Publicado: (2020)

Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma
por: Zhuang, Huiyu, et al.
Publicado: (2013)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
por: Wang, Kai, et al.
Publicado: (2022)

Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
por: Peng, Qiaohua, et al.
Publicado: (2017)

LINC00261 and the Adjacent Gene FOXA2 Are Epithelial Markers and Are Suppressed during Lung Cancer Tumorigenesis and Progression
por: Dhamija, Sonam, et al.
Publicado: (2018)

FoXA2 promotes esophageal squamous cell carcinoma progression by ZEB2 activation
por: Gao, Hanjing, et al.
Publicado: (2021)

Switch in FOXA1 Status Associates with Endometrial Cancer Progression
por: Tangen, Ingvild Løberg, et al.
Publicado: (2014)

Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway
por: Wang, Liyan, et al.
Publicado: (2022)

Epithelial Transcription Factor FOXA1 Regulates Prostate Cancer Immune Response
por: Brea, Lourdes T, et al.
Publicado: (2021)

Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition
por: Liu, Jinghua, et al.
Publicado: (2018)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
por: Domanskyi, Andrii, et al.
Publicado: (2014)

FOXA1 in prostate cancer
por: Dong, Hui-Yu, et al.
Publicado: (2022)

FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer
por: Wang, Baolei, et al.
Publicado: (2018)

FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity
por: Sahoo, Subhransu S., et al.
Publicado: (2022)

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
por: He, Shujiao, et al.
Publicado: (2017)

A functional variant rs4442975 modulating FOXA1-binding affinity does not influence the risk or progression of breast cancer in Chinese Han population
por: Zhang, Yi, et al.
Publicado: (2016)

MicroRNA-1246 Promotes Melanoma Progression Through Targeting FOXA2
por: Yu, Yanhua, et al.
Publicado: (2020)

Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer
por: Ding, Guo-wen, et al.
Publicado: (2020)

High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer
por: Sheta, Heba, et al.
Publicado: (2021)

Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients
por: Shang, Hui, et al.
Publicado: (2021)

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2019)

IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
por: Mansor, Rehanna, et al.
Publicado: (2020)

Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery
por: Qu, Hong, et al.
Publicado: (2015)

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer
por: Yang, Dong, et al.
Publicado: (2023)

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2
por: Liu, Qiuli, et al.
Publicado: (2020)

Genome-Wide Location Analysis Reveals Distinct Transcriptional Circuitry by Paralogous Regulators Foxa1 and Foxa2
por: Bochkis, Irina M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nu7t1f1ates8gu6p88v7nuj2vp